Defunct Company
Total Trials
4
As Lead Sponsor
0
As Collaborator
Total Enrollment
112
NCT05969717
Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic Dermatitis
Phase: Early Phase 1
Role: Collaborator
Start: Apr 12, 2023
Completion: Jun 30, 2025
NCT05886205
Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy
Start: Jun 5, 2023
Completion: Nov 13, 2025
NCT06138210
The Effect of GD-iExo-003 in Acute Ischemic Stroke
Phase: Phase 1
Start: May 27, 2024
Completion: Aug 30, 2025
NCT06810869
Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Stable Vitiligo
Start: Feb 5, 2025
Completion: Nov 17, 2026